Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 5/2024

Open Access 22-03-2024 | Septicemia | Original Article

A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives

Authors: Frida Oldendorff, Viveka Nordberg, Christian G Giske, Lars Navér

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 5/2024

Login to get access

Abstract

Purpose

To assess Gram-positive bacterial (GPB) bloodstream infection (BSI) in neonates, covering incidence, morbidity, mortality, antimicrobial resistance patterns and biomarkers in Region Stockholm, Sweden between 2006 and 2016.

Methods

A population-based retrospective epidemiological study including infants with GPB-BSI, admitted to the neonatal units at Karolinska University Hospital (KUH). Data were collected from patient records, the Swedish Neonatal Quality Register, the microbiological laboratory at KUH and the Swedish Public Health Agency.

Results

We identified 357 infants with GPB-BSI, representing an incidence of 1.47/1000 live births (LB). Group B streptococcus (GBS) was the most common pathogen causing BSI in full-term infants and early-onset sepsis (EOS) (0.20/1000 LB), while coagulase-negative staphylococci (CoNS) were predominant in infants born very preterm and in late-onset sepsis (LOS) (0.79/1000 LB). There were no fatal GBS BSI cases, but 10.2% developed meningitis. The GPB case fatality rate was 9.5% and the sepsis fatality rate 2.8%. In GPB-BSI, 1/10 did not have an elevated C-reactive protein level. Staphylococcus aureus (S. aureus) BSI increased during the study period, but no methicillin or vancomycin resistant strains were found. The antimicrobial resistance (AMR) rate was highest in CoNS isolates.

Conclusion

GPB-BSI was four times more common than Gram-negative BSI in neonates but resulted in lower mortality rate. GBS was the most common pathogen in full-term infants and in EOS. CoNS was the most common pathogen in LOS and infants born very preterm, and the AMR rate was high in these isolates. The increasing trend of S. aureus BSI indicates a need of further investigation.
Appendix
Available only for authorised users
Literature
2.
go back to reference Molloy EJ, Wynn JL, Bliss J et al (2020) Neonatal sepsis: need for consensus definition, collaboration and core outcomes. Pediatr Res 88(1):2–4PubMedCrossRef Molloy EJ, Wynn JL, Bliss J et al (2020) Neonatal sepsis: need for consensus definition, collaboration and core outcomes. Pediatr Res 88(1):2–4PubMedCrossRef
6.
go back to reference Leal YA, Álvarez-Nemegyei J, Lavadores-May AI et al (2019) Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med 32(17):2830–2836PubMedCrossRef Leal YA, Álvarez-Nemegyei J, Lavadores-May AI et al (2019) Cytokine profile as diagnostic and prognostic factor in neonatal sepsis. J Matern Fetal Neonatal Med 32(17):2830–2836PubMedCrossRef
7.
go back to reference Chiesa C, Pellegrini G, Panero A et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef Chiesa C, Pellegrini G, Panero A et al (2003) C-reactive protein, interleukin-6, and procalcitonin in the immediate postnatal period: influence of illness severity, risk status, antenatal and perinatal complications, and infection. Clin Chem 49(1):60–68PubMedCrossRef
10.
go back to reference Stoll BJ, Hansen N, Fanaroff AA et al (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt 1):285–291PubMedCrossRef Stoll BJ, Hansen N, Fanaroff AA et al (2002) Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110(2 Pt 1):285–291PubMedCrossRef
11.
go back to reference Tsai MH, Hsu JF, Chu SM et al (2014) Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 33(1):e7–e13PubMedCrossRef Tsai MH, Hsu JF, Chu SM et al (2014) Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J 33(1):e7–e13PubMedCrossRef
12.
go back to reference Gudjonsdottir MJ, Hentz E, Adlerberth I et al (2021) Late-onset neonatal infections 1997 to 2017 within a Cohort in Western Sweden-the last 21 years of a 43-Year surveillance. Pediatr Infect Dis J 40(4):359–364PubMedCrossRef Gudjonsdottir MJ, Hentz E, Adlerberth I et al (2021) Late-onset neonatal infections 1997 to 2017 within a Cohort in Western Sweden-the last 21 years of a 43-Year surveillance. Pediatr Infect Dis J 40(4):359–364PubMedCrossRef
13.
go back to reference Flannery DD, Ross RK, Mukhopadhyay S et al (2018) Temporal trends and Center Variation in early antibiotic use among premature infants. JAMA Netw Open 1(1):e180164PubMedPubMedCentralCrossRef Flannery DD, Ross RK, Mukhopadhyay S et al (2018) Temporal trends and Center Variation in early antibiotic use among premature infants. JAMA Netw Open 1(1):e180164PubMedPubMedCentralCrossRef
14.
go back to reference Nordberg V, Iversen A, Tidell A et al (2021) A decade of neonatal sepsis caused by gram-negative bacilli-a retrospective matched cohort study. Eur J Clin Microbiol Infect Dis 40(9):1803–1813PubMedPubMedCentralCrossRef Nordberg V, Iversen A, Tidell A et al (2021) A decade of neonatal sepsis caused by gram-negative bacilli-a retrospective matched cohort study. Eur J Clin Microbiol Infect Dis 40(9):1803–1813PubMedPubMedCentralCrossRef
15.
go back to reference Versporten A, Bielicki J, Drapier N et al (2016) The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 71(4):1106–1117PubMedCrossRef Versporten A, Bielicki J, Drapier N et al (2016) The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother 71(4):1106–1117PubMedCrossRef
17.
go back to reference Laxminarayan R, Matsoso P, Pant S et al (2016) Access to effective antimicrobials: a worldwide challenge. Lancet 387(10014):168–175PubMedCrossRef Laxminarayan R, Matsoso P, Pant S et al (2016) Access to effective antimicrobials: a worldwide challenge. Lancet 387(10014):168–175PubMedCrossRef
18.
go back to reference Wattal C, Kler N, Oberoi JK et al (2020) Neonatal Sepsis: mortality and morbidity in neonatal Sepsis due to Multidrug-Resistant (MDR) organisms: part 1. Indian J Pediatr 87(2):117–121PubMedCrossRef Wattal C, Kler N, Oberoi JK et al (2020) Neonatal Sepsis: mortality and morbidity in neonatal Sepsis due to Multidrug-Resistant (MDR) organisms: part 1. Indian J Pediatr 87(2):117–121PubMedCrossRef
20.
go back to reference Giannoni E, Dimopoulou V, Klingenberg C et al (2022) Analysis of antibiotic exposure and early-onset neonatal Sepsis in Europe, North America, and Australia. JAMA Netw Open 5(11):e2243691PubMedPubMedCentralCrossRef Giannoni E, Dimopoulou V, Klingenberg C et al (2022) Analysis of antibiotic exposure and early-onset neonatal Sepsis in Europe, North America, and Australia. JAMA Netw Open 5(11):e2243691PubMedPubMedCentralCrossRef
21.
go back to reference Arrieta MC, Arévalo A, Stiemsma L et al (2018) Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J Allergy Clin Immunol 142(2):424–434e10PubMedPubMedCentralCrossRef Arrieta MC, Arévalo A, Stiemsma L et al (2018) Associations between infant fungal and bacterial dysbiosis and childhood atopic wheeze in a nonindustrialized setting. J Allergy Clin Immunol 142(2):424–434e10PubMedPubMedCentralCrossRef
22.
go back to reference Arrieta MC, Stiemsma LT, Dimitriu PA et al (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7(307):307ra152PubMedCrossRef Arrieta MC, Stiemsma LT, Dimitriu PA et al (2015) Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med 7(307):307ra152PubMedCrossRef
23.
go back to reference Simonyte Sjödin K, Vidman L, Rydén P et al (2016) Emerging evidence of the role of gut microbiota in the development of allergic diseases. Curr Opin Allergy Clin Immunol 16(4):390–395PubMedCrossRef Simonyte Sjödin K, Vidman L, Rydén P et al (2016) Emerging evidence of the role of gut microbiota in the development of allergic diseases. Curr Opin Allergy Clin Immunol 16(4):390–395PubMedCrossRef
24.
go back to reference Alexander VN, Northrup V, Bizzarro MJ (2011) Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159(3):392–397PubMedPubMedCentralCrossRef Alexander VN, Northrup V, Bizzarro MJ (2011) Antibiotic exposure in the newborn intensive care unit and the risk of necrotizing enterocolitis. J Pediatr 159(3):392–397PubMedPubMedCentralCrossRef
25.
go back to reference Gasparrini AJ, Wang B, Sun X et al (2019) Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol 4(12):2285–2297PubMedPubMedCentralCrossRef Gasparrini AJ, Wang B, Sun X et al (2019) Persistent metagenomic signatures of early-life hospitalization and antibiotic treatment in the infant gut microbiota and resistome. Nat Microbiol 4(12):2285–2297PubMedPubMedCentralCrossRef
26.
go back to reference Song WS, Park HW, Oh MY et al (2022) Neonatal sepsis-causing bacterial pathogens and outcome of trends of their antimicrobial susceptibility a 20-year period at a neonatal intensive care unit. Clin Exp Pediatr 65(7):350–357PubMedCrossRef Song WS, Park HW, Oh MY et al (2022) Neonatal sepsis-causing bacterial pathogens and outcome of trends of their antimicrobial susceptibility a 20-year period at a neonatal intensive care unit. Clin Exp Pediatr 65(7):350–357PubMedCrossRef
27.
go back to reference Huncikova Z, Vatne A, Stensvold HJ et al (2023) Late-onset sepsis in very preterm infants in Norway in 2009–2018: a population-based study. Arch Dis Child Fetal Neonatal Ed 108(5):478–484PubMedCrossRef Huncikova Z, Vatne A, Stensvold HJ et al (2023) Late-onset sepsis in very preterm infants in Norway in 2009–2018: a population-based study. Arch Dis Child Fetal Neonatal Ed 108(5):478–484PubMedCrossRef
28.
go back to reference Johansson Gudjónsdóttir M, Elfvin A, Hentz E et al (2019) Changes in incidence and etiology of early-onset neonatal infections 1997–2017 - a retrospective cohort study in western Sweden. BMC Pediatr 19(1):490PubMedPubMedCentralCrossRef Johansson Gudjónsdóttir M, Elfvin A, Hentz E et al (2019) Changes in incidence and etiology of early-onset neonatal infections 1997–2017 - a retrospective cohort study in western Sweden. BMC Pediatr 19(1):490PubMedPubMedCentralCrossRef
29.
go back to reference Madrid L, Seale AC, Kohli-Lynch M et al (2017) Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: systematic review and Meta-analyses. Clin Infect Dis 65(suppl2):S160–s172PubMedPubMedCentralCrossRef Madrid L, Seale AC, Kohli-Lynch M et al (2017) Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: systematic review and Meta-analyses. Clin Infect Dis 65(suppl2):S160–s172PubMedPubMedCentralCrossRef
30.
go back to reference Stoll BJ, Hansen NI, Sánchez PJ et al (2011) Early onset neonatal sepsis: the burden of group B Streptococcal and E. Coli disease continues. Pediatrics 127(5):817–826PubMedPubMedCentralCrossRef Stoll BJ, Hansen NI, Sánchez PJ et al (2011) Early onset neonatal sepsis: the burden of group B Streptococcal and E. Coli disease continues. Pediatrics 127(5):817–826PubMedPubMedCentralCrossRef
31.
go back to reference Golińska E, Kozień Ł, Tomusiak-Plebanek A et al (2023) Epidemiology of neonatal sepsis in two neonatal intensive care units in Krakow, Poland in 2016–2017 years. BMC Infect Dis 23(1):827PubMedPubMedCentralCrossRef Golińska E, Kozień Ł, Tomusiak-Plebanek A et al (2023) Epidemiology of neonatal sepsis in two neonatal intensive care units in Krakow, Poland in 2016–2017 years. BMC Infect Dis 23(1):827PubMedPubMedCentralCrossRef
32.
go back to reference Håkansson S, Lilja M, Jacobsson B et al (2017) Reduced incidence of neonatal early-onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort. Acta Obstet Gynecol Scand 96(12):1475–1483PubMedCrossRef Håkansson S, Lilja M, Jacobsson B et al (2017) Reduced incidence of neonatal early-onset group B streptococcal infection after promulgation of guidelines for risk-based intrapartum antibiotic prophylaxis in Sweden: analysis of a national population-based cohort. Acta Obstet Gynecol Scand 96(12):1475–1483PubMedCrossRef
33.
go back to reference Hornik CP, Fort P, Clark RH et al (2012) Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 88(Suppl 2):S69–74PubMedPubMedCentralCrossRef Hornik CP, Fort P, Clark RH et al (2012) Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 88(Suppl 2):S69–74PubMedPubMedCentralCrossRef
34.
go back to reference Nickel N, Brooks S, Mize C et al (2022) Reducing Staphylococcus aureus infections in the neonatal intensive care unit. J Perinatol 42(11):1540–1545PubMedCrossRef Nickel N, Brooks S, Mize C et al (2022) Reducing Staphylococcus aureus infections in the neonatal intensive care unit. J Perinatol 42(11):1540–1545PubMedCrossRef
35.
go back to reference Gagliotti C, Högberg LD, Billström H et al (2021) Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018. Euro Surveill. ;26(46) Gagliotti C, Högberg LD, Billström H et al (2021) Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018. Euro Surveill. ;26(46)
36.
go back to reference Shadbolt R, We MLS, Kohan R et al (2022) Neonatal Staphylococcus Aureus Sepsis: a 20-year western Australian experience. J Perinatol 42(11):1440–1445PubMedPubMedCentralCrossRef Shadbolt R, We MLS, Kohan R et al (2022) Neonatal Staphylococcus Aureus Sepsis: a 20-year western Australian experience. J Perinatol 42(11):1440–1445PubMedPubMedCentralCrossRef
37.
go back to reference Hindy JR, Quintero-Martinez JA, Lee AT et al (2022) Incidence trends and Epidemiology of Staphylococcus aureus Bacteremia: a systematic review of Population-Based studies. Cureus 14(5):e25460PubMedPubMedCentral Hindy JR, Quintero-Martinez JA, Lee AT et al (2022) Incidence trends and Epidemiology of Staphylococcus aureus Bacteremia: a systematic review of Population-Based studies. Cureus 14(5):e25460PubMedPubMedCentral
38.
go back to reference Ericson JE, Popoola VO, Smith PB et al (2015) Burden of Invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr 169(12):1105–1111PubMedPubMedCentralCrossRef Ericson JE, Popoola VO, Smith PB et al (2015) Burden of Invasive Staphylococcus aureus infections in hospitalized infants. JAMA Pediatr 169(12):1105–1111PubMedPubMedCentralCrossRef
39.
go back to reference Russell NJ, Stöhr W, Plakkal N et al (2023) Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS). PLoS Med 20(6):e1004179PubMedPubMedCentralCrossRef Russell NJ, Stöhr W, Plakkal N et al (2023) Patterns of antibiotic use, pathogens, and prediction of mortality in hospitalized neonates and young infants with sepsis: a global neonatal sepsis observational cohort study (NeoOBS). PLoS Med 20(6):e1004179PubMedPubMedCentralCrossRef
41.
go back to reference Rasigade JP, Raulin O, Picaud JC et al (2012) Methicillin-resistant Staphylococcus capitis with reduced Vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS ONE 7(2):e31548PubMedPubMedCentralCrossRef Rasigade JP, Raulin O, Picaud JC et al (2012) Methicillin-resistant Staphylococcus capitis with reduced Vancomycin susceptibility causes late-onset sepsis in intensive care neonates. PLoS ONE 7(2):e31548PubMedPubMedCentralCrossRef
42.
go back to reference Peixoto PB, Massinhani FH, Netto Dos Santos KR et al (2020) Methicillin-resistant Staphylococcus epidermidis isolates with reduced Vancomycin susceptibility from bloodstream infections in a neonatal intensive care unit. J Med Microbiol 69(1):41–45PubMedCrossRef Peixoto PB, Massinhani FH, Netto Dos Santos KR et al (2020) Methicillin-resistant Staphylococcus epidermidis isolates with reduced Vancomycin susceptibility from bloodstream infections in a neonatal intensive care unit. J Med Microbiol 69(1):41–45PubMedCrossRef
43.
go back to reference Huncikova Z, Stensvold HJ, Øymar KAA et al (2023) Variation in antibiotic consumption in very preterm infants-a 10 year population-based study. J Antimicrob Chemother. Nov 21 Huncikova Z, Stensvold HJ, Øymar KAA et al (2023) Variation in antibiotic consumption in very preterm infants-a 10 year population-based study. J Antimicrob Chemother. Nov 21
44.
go back to reference Hofer N, Zacharias E, Müller W et al (2012) An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 102(1):25–36PubMedCrossRef Hofer N, Zacharias E, Müller W et al (2012) An update on the use of C-reactive protein in early-onset neonatal sepsis: current insights and new tasks. Neonatology 102(1):25–36PubMedCrossRef
Metadata
Title
A decade of neonatal sepsis in Stockholm, Sweden: Gram-positive pathogens were four times as common as Gram-negatives
Authors
Frida Oldendorff
Viveka Nordberg
Christian G Giske
Lars Navér
Publication date
22-03-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 5/2024
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-024-04809-8

Other articles of this Issue 5/2024

European Journal of Clinical Microbiology & Infectious Diseases 5/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine